Modulation of Therapeutic ResponseIn the interest of improving cancer treatment, considerable attention has been placed on the modification of radiation damage. The major goal of this project is to define and understand those aspects of tumor physiology, including cellular and molecular processes that ultimately define the very nature of a tumor such that a particular dose of ionizing radiation, when used will be more effective. We have recently shown that radiation-induced gene expression profiles differ significantly for cells exposed in vitro versus the same cells growing as a solid tumor in vivo further underscoring the influence of the tumor microenvironment on the radiation response. The interaction of a variety of chemotherapy and/or molecularly targeted agents with radiation is under study to determine if tumors can be made more sensitive or normal tissues more resistant to radiation treatment. Research continues with halofuginone, an inhibitor of TGF beta signaling pathway, which exhibits cytotoxicity and radiosensitization to a variety of different types of human tumor cell lines and protects against radiation-induced late effects in normal tissues in vivo. Importantly we have shown that halofuginone can protect against radiation-induced soft tissue fibrosis even when administered two weeks post-irradiation. Additional agents that block the TGF beta-signaling pathway are being evaluated with the goal of identifying and implementing agents that will provide selective radioprotection of normal tissues with perhaps sensitization of tumor. Another major goal of this project is to develop functional imaging techniques to better characterize factors important in the tumor microenvironment and normal tissues that may prevent or diminish agents from impacting radiation response. It is well established that hypoxia is a major determinant of radiation sensitivity and that many human tumors are hypoxic. Therefore, we are using several murine tumor models to study tumor hypoxia. Our approach is to use current invasive techniques and extend that information to non-invasive methods that are under development, such that patient tumor treatment profiles may optimized on an individual basis. We have demonstrated that placement of lithium phthalocyanine crystals in tissue provides an accurate means of assessing tissue oxygen levels by electron paramagnetic resonance (EPR). Using novel EPR equipment developed in the Radiation Biology Branch we have recently shown that non-invasive tissue oxygen concentration can be evaluated in mice using a specific redox probe contrast agent. Three-dimensional oxygen images can be acquired in less than 3 minutes with oxygen resolution to 0.5 mm. Our EPR non-invasive functional imaging approaches should enhance our ability to better understand the tumor microenvironment and develop strategies to effectively attack potential barriers that currently limit the effectiveness of cancer treatment modalities.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC006321-27
Application #
7331383
Study Section
(RBB)
Project Start
Project End
Budget Start
Budget End
Support Year
27
Fiscal Year
2006
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Samuni, Yuval; Cook, John A; Choudhuri, Rajani et al. (2010) Inhibition of adipogenesis by Tempol in 3T3-L1 cells. Free Radic Biol Med 49:667-73
Guo, Zhanjun; Tsai, Mong-Hsun; Shiao, Yih-Horng et al. (2008) DNA (cytosine-5)-methyltransferase 1 as a mediator of mutant p53-determined p16(ink4A) down-regulation. J Biomed Sci 15:163-8
Soule, Benjamin P; Hyodo, Fuminori; Matsumoto, Ken-Ichiro et al. (2007) The chemistry and biology of nitroxide compounds. Free Radic Biol Med 42:1632-50
Soule, Benjamin P; Hyodo, Fuminori; Matsumoto, Ken-Ichiro et al. (2007) Therapeutic and clinical applications of nitroxide compounds. Antioxid Redox Signal 9:1731-43
Arany, Praveen R; Flanders, Kathleen C; DeGraff, William et al. (2007) Absence of Smad3 confers radioprotection through modulation of ERK-MAPK in primary dermal fibroblasts. J Dermatol Sci 48:35-42
Soule, Benjamin P; Brown, Jared M; Kushnir-Sukhov, Nataliya M et al. (2007) Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol 179:3276-86
Cotrim, Ana P; Hyodo, Fuminori; Matsumoto, Ken-Ichiro et al. (2007) Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 13:4928-33
Tsai, Mong-Hsun; Cook, John A; Chandramouli, Gadisetti V R et al. (2007) Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res 67:3845-52
Simone, Nicole L; Soule, Benjamin P; Gerber, Lynn et al. (2007) Oral Pirfenidone in patients with chronic fibrosis resulting from radiotherapy: a pilot study. Radiat Oncol 2:19
Matsumoto, Ken-Ichiro; Szajek, Lawrence; Krishna, Murali C et al. (2007) The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography. Int J Oncol 30:873-81

Showing the most recent 10 out of 23 publications